What is Febuxostat Tablets 80mg Febuget used for?
Febuxostat Tablets 80mg Febuget is used to treat hyperuricemia (excess uric acid in the blood) in gout patients who have failed to respond to allopurinol or who are unable to take allopurinol. This medication inhibits the enzyme xanthine oxidase. It works by causing the body to create less uric acid.
When should I stop using febuxostat?
Remember to take febuxostat every day to avoid a gout attack. It could take up to six months to fully activate. It has no impact during a gout attack, but you should continue to take it on a daily basis even if this happens.
Is febuxostat effective at lowering uric acid levels?
Febuxostat is a xanthine oxidase (XO) inhibitor that is prescribed to help people with gout lower their blood uric acid levels. Uric acid is made up of purines, which are the building blocks of the acid.
What are the adverse effects of Febuxostat Tablets 80mg Febuget tablet?
- pain in the arms, back, or jaw.
- Stools that are dark and tarry.
- A nasal bleed
- Pain or discomfort in the chest.
- Urine that is hazy
- decreases urine frequency or volume.
- I have diarrhea.
- Breathing that is laborious or labored.
For more click here.
What is the best way to take Febuxostat Tablets 80mg Febuget?
- Time to take febuxostat: Take febuxostat at the same time every day. It’s better to take it first thing in the morning.
- To avoid gout attacks, take febuxostat every day. It may take a few weeks before you notice all of febuxostat’s benefits.
- If you forget to take your tablet, remember to do so as soon as possible.
Is Febuxostat Tablets 80mg Febuget beneficial to the kidneys?
Febuxostat has been found to be safe and effective in patients with moderate to severe renal impairment, and there is no need to change the dose in these cases. To assess the efficacy and safety of febuxostat in patients with CKD and hyperuricemia, we conducted a systematic review and meta-analysis.
Is Febuxostat Tablets 80mg Febuget toxic to the liver?
Introduction. Febuxostat is a nonpurine xanthine oxidase inhibitor that has just been approved for the treatment of gout. Although chronic febuxostat medication has been linked to modest serum aminotransferase increases, no cases of clinically obvious acute liver injury have been reported.
Is febuxostat capable of lowering creatinine levels?
The absolute value of the drop in serum creatinine in the febuxostat group was minimal (0.03 mg/dL), despite the fact that it was much lower. Given the short duration of the trial, more prolonged suppression could have resulted in more change.